New biomarker to predict clinical outcome of sorafenib-treated hepatocellular carcinoma Sep. 12, 2011
FDA clears Fujirebio immunoassay for use in ROMA algorithm to determine ovarian cancer risk Sep. 8, 2011
Study links SNPs to secondary malignant neoplasms due to radiation for pediatric Hodgkin's lymphoma Sep. 2, 2011
RSS